Other malabsorption causes include: Atrophic gastritis and reduced gastric acid production (common in older adults) Gastrointestinal surgery, particularly gastrectomy, ileal resection, or bariatric surgery (especially gastric bypass) Inflammatory bowel disease affecting the terminal ileum (Crohn's disease) Coeliac disease and other small bowel disorders Chronic pancreatitis affecting enzyme secretion Helicobacter pylori infection (may contribute to reduced absorption) Medication-related deficiency is increasingly recognised
Scientific References Kraus D, Yang Q, Kong D, et al
AOD-9604 is subject to stock availability
5-Amino-1MQ 50mg (60 Capsules) Buy 5-Amino-1MQ 50mg for sale by Peptide Sciences Advanced NNMT Inhibition for Metabolic Research 5-Amino-1MQ (5-Amino-1-methylquinolinium) is a potent, small-molecule inhibitor of the nicotinamide N-methyltransferase (NNMT) enzyme
One of the clinical trials was performed in Australia, where 300 obese individuals were administered the peptide, and all the subjects experienced weight loss significantly
Lipolysis Stimulation and Lipogenesis Inhibition Studies in rodent models showed that AOD-9604 peptide preferentially triggers fat release from obese adipocytes more than from lean fat cells
